-+ 0.00%
-+ 0.00%
-+ 0.00%

INSILICO MEDICINE ANNOUNCES ORAL PRESENTATION AT ESMO 2026 FOR PHASE 1 CLINICAL STUDY OF ISM6331 IN MESOTHELIOMA AND ADVANCED SOLID TUMORS

Reuters·07/27/2026 12:00:04

Please log in to view news